FindTrial
Sign In

Development of a predictive model for the outcome of electrical cardioversion therapy in patients with recurrence after surgical ablation of atrial fibrillation

Development of a predictive model for the outcome of electrical cardioversion therapy in patients with recurrence after surgical ablation of atrial fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058219
Enrollment
Unknown
Registered
2022-04-02
Start date
2022-05-01
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent atrial fibrillation after surgical ablation

Interventions

Group 1 :
Group 2:

Sponsors

Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients with recurrent atrial fibrillation after surgical ablation: 2. Patients with persistent atrial fibrillation, atrial fibrillation lasting more than 15 min or persistent atrial flutter were defined as recurrent atrial fibrillation after 24 h holter electrocardiogram detection 2 months after surgery (blank period).

Exclusion criteria

Exclusion criteria: 1. Patients who have not undergone surgical procedures; 2. Patients with thrombus in the left atrium as indicated by cardiac ultrasound examination; 3. Subjects with incomplete medical record information, incomplete treatment information, or missing other relevant tests are excluded.

Countries

China

Contacts

Public ContactWang Dongjin

Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School

568886898@qq.com+86 25 83105117

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026